NCT06349616

Cooling Strategies for Older Adults in the Heat

Acute and Chronic Interventions to Improve Heat Loss During Uncompensable Humid Heat Stress in Older Adults
Penn State University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Aging
Drug/Device/Intervention
Intermittent cold-water hand and forearm immersion
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Penn State University
Location
University Park, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Dec 01, 2026
Enrollment
20 participants
Primary outcome

Core temperature,Heart rate,Blood Pressure

Summary

The earth's climate is warming, and the number of heat waves has increased in recent years.
 At the same time, the number of adults over the age of 65 is growing. Humans sweat and
 increase blood flow to the skin to cool their body when they get hot. Older adults do not do
 this as well as young adults. This makes it harder to safely be in warm and/or humid
 conditions. It is important to learn about cooling strategies for older adults to safely be
 in warm and/or humid conditions.
 
 There is compelling evidence that intermittent hand and forearm cold-water immersion
 effectively reduces the rise of core temperature during heat stress in older adults. However,
 it is still unknown if this is an effective cooling strategy for older adults. Furthermore,
 our laboratory has shown that folic acid supplementation improves blood flow responses in
 older adults. This may be beneficial to older adults during heat stress.

ICD-10 classifications
Alzheimer diseaseAgenesis and underdevelopment of noseAgenesis of lungAdult-onset Still diseaseChoroidal degeneration
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06349616
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06349616 through Pure Global AI's free database. This phase not specified trial is sponsored by Penn State University and is currently Not yet recruiting. The study focuses on Aging. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.